Center for Health Policy & Outcomes: In the News

Change In PSA Level Does Not Predict Prostate Cancer
Dr. Andrew Vickers published a paper in the Journal of the National Cancer Institute demonstrating that changes in PSA were not a reliable indicator for prostate cancer in men whose PSA was low. The paper gained considerable press attention, including The New York Times and NPR.
New York Times
NPR

March 7, 2011

Plan to Cut Medicare Without Stifling Innovation: Proving Innovation in Medicare
A proposal by Dr. Steven Pearson of Massachusetts General Hospital and Dr. Peter Bach was featured in The New York Times. Their proposal lays out a system in which Medicare would reimburse equally for procedures that produce similar patient outcomes. Their system provides higher payments for new services, but stipulates that the new service must be proven more effective within a limited time frame. The proposal was also commented on by Peter Orzag, the former director of the White House Office of Management and Budget: Reforming Medicare's Payment System.
New York Times
October 19, 2010

Advanced Cancer Patients Get Unneeded Tests for Other Tumors, Study Finds
Dr. Camelia Sima's article “Cancer Screening Among Patients With Advanced Cancer” is profiled in The Wall Street Journal. Her study found that patients with advanced stages of lung, colorectal, breast, gastroesophageal, and pancreatic cancers received screening tests that were unlikely to provide a meaningful benefit to the patient.
Bloomberg News
October 12, 2010

Simplifying the Decision for a Prostate Screening
Dr. Andrew Vickers' article “Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study” is highlighted in The New York Times.
New York Times
September 27, 2010